查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1810911

2025年全球基因检测市场报告

Hereditary Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年基因检测市场将强劲成长，2029年将达到93.5亿美元，复合年增长率为9.0%。预测期内的增长可归因于公共和私人基因组学倡议之间合作的加强、对无创产前检测 (NIPT) 的需求不断增长、基因检测组合和套件类型的不断增加、其在全民筛检项目中的应用日益广泛，以及对预防性和精准公共卫生的日益重视。这段时期的主要趋势包括新一代定序 (NGS) 的进步、NIPT 的创新、生物资讯学平台的进步、照护现场基因检测仪器的改进以及多基因组合检测的发展。

遗传病患病率的上升预计将推动未来基因检测市场的成长。遗传疾病是由个体去氧核糖核酸(DNA) 异常或突变引起的疾病，可从父母一方或双方遗传，或自然发生。遗传病患病率的上升部分是由于父母老化，这增加了将基因突变遗传给后代的可能性。基因检测可帮助遗传疾病患者识别遗传突变、实现早期诊断、指导个人化治疗并协助计划生育决策。例如，2024 年 10 月，英国慈善机构囊性纤维化信託基金报告称，註册的囊肿纤维化患者人数从 2022 年的 11,148 人增加到 2023 年的 11,318 人。因此，遗传病患病率的上升正在推动基因检测市场的发展。

基因检测市场的主要企业正专注于基因检测套组的技术进步，以提高准确性、缩短週转时间并扩大对更广泛基因突变的检测。基因检测套组是一种诊断工具，旨在分析个体的 DNA，以识别与遗传性疾病和风险因素相关的突变或变异。例如，2023 年 7 月，专门生产遗传性疾病 DNA 诊断套件的瑞典生物技术公司 Devyser Diagnostics AB 推出了两款新的标靶下一代定序试剂套件：Devyser LynchFAP 和 Devyser BRCA PALB2。 Devyser LynchFAP 能够全面分析 PMS2（解决假基因 PMS2CL 带来的挑战）和其他九个与遗传性大肠直肠癌症候群相关的关键基因。 Devyser BRCA PALB2 是一种简化的单管解决方案，用于筛检血液和肿瘤样本中的 BRCA1、BRCA2 和 PALB2 突变。它旨在透过易于使用的测序和专用软体支援高效的实验室工作流程，以可靠地检测遗传性癌症风险。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球基因检测：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球基因检测市场：成长率分析
  • 全球基因检测市场表现：规模与成长，2019-2024
  • 全球基因检测市场预测：规模与成长，2024-2029，2034
  • 全球基因检测：总目标市场（TAM）

第六章 市场细分

  • 全球基因检测市场（按检测类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 预测测试
  • 携带者检测
  • 产前检查
  • 新生儿筛检
  • 诊断测试
  • 其他的
  • 全球基因检测市场（依样本类型）：绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 血液样本
  • 唾液样本
  • 组织样本
  • 口腔拭子
  • 尿液样本
  • 全球基因检测市场（依所用技术、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 下一代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 桑格定序
  • 微阵列技术
  • 全基因组定序（WGS）
  • 全球基因检测市场的应用、表现及预测（2019-2024、2024-2029、2034）
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 代谢紊乱
  • 其他的
  • 全球基因检测市场（按最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 研究所
  • 製药公司
  • 病人和消费者
  • 全球基因检测市场：预测性测试细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 1 型乳癌(BRCA1) 和第 2 型乳癌(BRCA2) 基因突变检测
  • 林奇症候群检测
  • 遗传性高胆固醇症血症检测
  • 亨丁顿舞蹈症检测
  • 心肌病基因检测
  • 全球基因检测市场：载体检测细分，按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 囊肿纤维化带因者筛检
  • 戴-萨克斯病带因者筛检
  • 脊髓性肌肉萎缩症 (SMA) 带因者筛检
  • 地中海贫血带因者筛检
  • 镰状细胞带因者检测
  • 全球基因检测市场：产前检测细分市场，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 非侵入性产前检测（NIPT）
  • 绒毛膜绒毛采样（CVS）
  • 羊膜穿刺术
  • 扩大带因者筛检（产前）
  • 免费胎儿去氧核糖核酸检测
  • 全球基因检测市场：新生儿筛检细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 苯酮尿症（PKU）筛检
  • 先天性甲状腺机能低下症筛检
  • 囊肿纤维化筛检
  • 镰状细胞疾病筛检
  • 听力损失和代谢紊乱小组
  • 全球基因检测市场：诊断测试细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 罕见疾病基因检测
  • 遗传性癌症诊断测试
  • 心臟发育诊断小组
  • 神经遗传疾病检测
  • 单基因疾病检测组
  • 全球基因检测市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物基因组学检测
  • 胚胎胚胎着床前遗传学诊断（PGD）
  • 全EXOME定序（WES）
  • 全基因组定序（WGS）
  • 粒线体去氧核糖核酸检测

第七章 区域和国家分析

  • 全球基因检测市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球基因检测市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基因检测市场：竞争格局
  • 基因检测市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第31章：其他领先和创新企业

  • Illumina Inc.
  • CooperSurgical Inc.
  • QIAGEN NV
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc
  • Invitae Corporation
  • GeneDx LLC
  • Twist Bioscience Corporation
  • Color Health Inc.
  • MedGenome Inc
  • SOPHiA GENETICS SA
  • Gene By Gene Ltd.
  • Dante Labs Inc.
  • 23mofang Co. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年基因检测市场：提供新机会的国家
  • 2029 年基因检测市场：细分领域带来新机会
  • 2029年基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37011

Hereditary testing, also known as genetic testing for inherited conditions, involves analyzing an individual's DNA to detect genetic mutations or variations inherited from their parents. These tests help evaluate the risk of developing or passing on inherited diseases, assist in diagnosing genetic disorders, and support personalized treatment or preventive care decisions.

The primary types of hereditary testing include predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic testing, and others. Predictive testing is used to determine the likelihood that an individual will develop a particular disease or condition in the future, before symptoms arise. Sample types for these tests include blood, saliva, tissue, buccal swabs, and urine. The technologies employed range from next-generation sequencing (NGS), polymerase chain reaction (PCR), Sanger sequencing, microarray technology, to whole genome sequencing (WGS). These tests are applied in various fields such as oncology, cardiovascular diseases, neurological disorders, metabolic disorders, and more, and are utilized by a wide range of end users including hospitals, diagnostic labs, research institutions, pharmaceutical companies, patients, and consumers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The hereditary testing market research report is one of a series of new reports from The Business Research Company that provides hereditary testing market statistics, including hereditary testing industry global market size, regional shares, competitors with a hereditary testing market share, detailed hereditary testing market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary testing industry. The hereditary testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hereditary testing market size has grown strongly in recent years. It will grow from $6.05 billion in 2024 to $6.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be credited to increasing parental age, broader use in cancer risk assessment, heightened demand for early diagnosis and prevention, a rising burden of rare and chronic diseases, improved access to genetic counseling services, and greater adoption of hereditary testing in reproductive health.

The hereditary testing market size is expected to see strong growth in the next few years. It will grow to $9.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in the forecast period can be attributed to expanding collaborations between public and private genomic initiatives, rising demand for non-invasive prenatal testing (NIPT), an increasing variety of genetic testing panels and kits, greater use in population-wide screening programs, and a stronger focus on preventive and precision public health. Key trends during this period include advancements in next-generation sequencing (NGS), technological innovations in NIPT, progress in bioinformatics platforms, improvements in point-of-care genetic testing devices, and developments in multi-gene panel testing.

The rising prevalence of genetic disorders is expected to drive the growth of the hereditary testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's deoxyribonucleic acid (DNA), inherited from one or both parents or occurring spontaneously. The increase in genetic disorders is partly due to higher parental age, which raises the chances of passing genetic mutations to offspring. Hereditary testing aids patients with genetic disorders by enabling early diagnosis, guiding personalized treatments, and assisting family planning decisions through the identification of inherited mutations. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity, reported that the number of registered cystic fibrosis patients increased to 11,318 in 2023, up from 11,148 in 2022. Thus, the growing prevalence of genetic disorders is fueling the hereditary testing market.

Key players in the hereditary testing market are focusing on technological advancements in genetic test kits to improve accuracy, shorten turnaround times, and expand the detection of a wider range of genetic mutations. Genetic test kits are diagnostic tools designed to analyze an individual's DNA to identify mutations or variations linked to inherited diseases or risk factors. For instance, in July 2023, Devyser Diagnostics AB, a Sweden-based biotech company specializing in DNA diagnostic kits for hereditary diseases, launched two new targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP allows comprehensive analysis of PMS2 (addressing challenges from its pseudogene PMS2CL) along with nine other key genes associated with hereditary colorectal cancer syndromes. Devyser BRCA PALB2 provides a streamlined single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples, designed to support efficient lab workflows with user-friendly sequencing and dedicated software for confident detection of hereditary cancer risks.

In May 2025, GeneDx LLC, a US-based biotechnology firm specializing in genetic testing, acquired Fabric Genomics for an undisclosed sum. This acquisition aims to enhance GeneDx's genomic interpretation capabilities by integrating Fabric Genomics' AI-powered platform, thereby strengthening its hereditary disease diagnostic offerings and enabling faster, more scalable genetic analysis. Fabric Genomics is a US-based computational genomics company providing hereditary testing solutions.

Major players in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

North America was the largest region in the hereditary testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hereditary testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hereditary testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hereditary testing market includes revenues earned by entities through services such as genetic screening, pharmacogenetic testing, and presymptomatic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hereditary Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hereditary testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hereditary testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hereditary testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Diagnostic Testing; Other Test Types
  • 2) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Buccal Swabs; Urine Samples
  • 3) By Technology Used: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Sanger Sequencing; Microarray Technology; Whole Genome Sequencing (WGS)
  • 4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders; Other Applications
  • 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Patients And Consumers
  • Subsegments:
  • 1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing; Lynch Syndrome Testing; Familial Hypercholesterolemia Testing; Huntington's Disease Testing; Cardiomyopathy Genetic Testing
  • 2) By Carrier Testing: Cystic Fibrosis Carrier Screening; Tay-Sachs Carrier Screening; Spinal Muscular Atrophy (SMA) Carrier Screening; Thalassemia Carrier Screening; Sickle Cell Carrier Testing
  • 3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT); Chorionic Villus Sampling (CVS); Amniocentesis; Expanded Carrier Screening (Prenatal Context); Cell-Free Fetal Deoxyribonucleic Acid Testing
  • 4) By Newborn Screening: Phenylketonuria (PKU) Screening; Congenital Hypothyroidism Screening; Cystic Fibrosis Screening; Sickle Cell Disease Screening; Hearing Loss and Metabolic Disorder Panels
  • 5) By Diagnostic Testing: Rare Disease Genetic Testing; Inherited Cancer Diagnostic Testing; Cardiogenetic Diagnostic Panels; Neurogenetic Disorder Testing; Monogenic Disease Panels
  • 6) By Other Test Types: Pharmacogenomics Testing; Preimplantation Genetic Diagnosis (PGD); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS); Mitochondrial Deoxyribonucleic Acid Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; CooperSurgical Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc; Invitae Corporation; GeneDx LLC; Twist Bioscience Corporation; Color Health Inc.; MedGenome Inc; SOPHiA GENETICS SA; Gene By Gene Ltd.; Dante Labs Inc.; 23mofang Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hereditary Testing Market Characteristics

3. Hereditary Testing Market Trends And Strategies

4. Hereditary Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hereditary Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hereditary Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hereditary Testing Market Growth Rate Analysis
  • 5.4. Global Hereditary Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hereditary Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hereditary Testing Total Addressable Market (TAM)

6. Hereditary Testing Market Segmentation

  • 6.1. Global Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Carrier Testing
  • Prenatal Testing
  • Newborn Screening
  • Diagnostic Testing
  • Other Test Types
  • 6.2. Global Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Saliva Samples
  • Tissue Samples
  • Buccal Swabs
  • Urine Samples
  • 6.3. Global Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Sanger Sequencing
  • Microarray Technology
  • Whole Genome Sequencing (WGS)
  • 6.4. Global Hereditary Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Disorders
  • Other Applications
  • 6.5. Global Hereditary Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies
  • Patients And Consumers
  • 6.6. Global Hereditary Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer 1 (BRCA1) And Breast Cancer 2 (BRCA2) Gene Mutation Testing
  • Lynch Syndrome Testing
  • Familial Hypercholesterolemia Testing
  • Huntington's Disease Testing
  • Cardiomyopathy Genetic Testing
  • 6.7. Global Hereditary Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cystic Fibrosis Carrier Screening
  • Tay-Sachs Carrier Screening
  • Spinal Muscular Atrophy (SMA) Carrier Screening
  • Thalassemia Carrier Screening
  • Sickle Cell Carrier Testing
  • 6.8. Global Hereditary Testing Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT)
  • Chorionic Villus Sampling (CVS)
  • Amniocentesis
  • Expanded Carrier Screening (Prenatal Context)
  • Cell-Free Fetal Deoxyribonucleic Acid Testing
  • 6.9. Global Hereditary Testing Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phenylketonuria (PKU) Screening
  • Congenital Hypothyroidism Screening
  • Cystic Fibrosis Screening
  • Sickle Cell Disease Screening
  • Hearing Loss And Metabolic Disorder Panels
  • 6.10. Global Hereditary Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rare Disease Genetic Testing
  • Inherited Cancer Diagnostic Testing
  • Cardiogenetic Diagnostic Panels
  • Neurogenetic Disorder Testing
  • Monogenic Disease Panels
  • 6.11. Global Hereditary Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacogenomics Testing
  • Preimplantation Genetic Diagnosis (PGD)
  • Whole Exome Sequencing (WES)
  • Whole Genome Sequencing (WGS)
  • Mitochondrial Deoxyribonucleic Acid Testing

7. Hereditary Testing Market Regional And Country Analysis

  • 7.1. Global Hereditary Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hereditary Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hereditary Testing Market

  • 8.1. Asia-Pacific Hereditary Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hereditary Testing Market

  • 9.1. China Hereditary Testing Market Overview
  • 9.2. China Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hereditary Testing Market

  • 10.1. India Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hereditary Testing Market

  • 11.1. Japan Hereditary Testing Market Overview
  • 11.2. Japan Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hereditary Testing Market

  • 12.1. Australia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hereditary Testing Market

  • 13.1. Indonesia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hereditary Testing Market

  • 14.1. South Korea Hereditary Testing Market Overview
  • 14.2. South Korea Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hereditary Testing Market

  • 15.1. Western Europe Hereditary Testing Market Overview
  • 15.2. Western Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hereditary Testing Market

  • 16.1. UK Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hereditary Testing Market

  • 17.1. Germany Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hereditary Testing Market

  • 18.1. France Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hereditary Testing Market

  • 19.1. Italy Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hereditary Testing Market

  • 20.1. Spain Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hereditary Testing Market

  • 21.1. Eastern Europe Hereditary Testing Market Overview
  • 21.2. Eastern Europe Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hereditary Testing Market

  • 22.1. Russia Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hereditary Testing Market

  • 23.1. North America Hereditary Testing Market Overview
  • 23.2. North America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hereditary Testing Market

  • 24.1. USA Hereditary Testing Market Overview
  • 24.2. USA Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hereditary Testing Market

  • 25.1. Canada Hereditary Testing Market Overview
  • 25.2. Canada Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hereditary Testing Market

  • 26.1. South America Hereditary Testing Market Overview
  • 26.2. South America Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hereditary Testing Market

  • 27.1. Brazil Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hereditary Testing Market

  • 28.1. Middle East Hereditary Testing Market Overview
  • 28.2. Middle East Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hereditary Testing Market

  • 29.1. Africa Hereditary Testing Market Overview
  • 29.2. Africa Hereditary Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hereditary Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hereditary Testing Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hereditary Testing Market Competitive Landscape And Company Profiles

  • 30.1. Hereditary Testing Market Competitive Landscape
  • 30.2. Hereditary Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hereditary Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. CooperSurgical Inc.
  • 31.3. QIAGEN N.V
  • 31.4. Natera Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Fulgent Genetics Inc
  • 31.7. Invitae Corporation
  • 31.8. GeneDx LLC
  • 31.9. Twist Bioscience Corporation
  • 31.10. Color Health Inc.
  • 31.11. MedGenome Inc
  • 31.12. SOPHiA GENETICS SA
  • 31.13. Gene By Gene Ltd.
  • 31.14. Dante Labs Inc.
  • 31.15. 23mofang Co. Ltd.

32. Global Hereditary Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hereditary Testing Market

34. Recent Developments In The Hereditary Testing Market

35. Hereditary Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Hereditary Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hereditary Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hereditary Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer